1. Home
  2. MTRN vs NVAX Comparison

MTRN vs NVAX Comparison

Compare MTRN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTRN
  • NVAX
  • Stock Information
  • Founded
  • MTRN 1931
  • NVAX 1987
  • Country
  • MTRN United States
  • NVAX United States
  • Employees
  • MTRN N/A
  • NVAX N/A
  • Industry
  • MTRN Industrial Specialties
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MTRN Industrials
  • NVAX Health Care
  • Exchange
  • MTRN Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • MTRN 1.7B
  • NVAX 1.3B
  • IPO Year
  • MTRN N/A
  • NVAX 1995
  • Fundamental
  • Price
  • MTRN $79.80
  • NVAX $7.45
  • Analyst Decision
  • MTRN Buy
  • NVAX Buy
  • Analyst Count
  • MTRN 2
  • NVAX 5
  • Target Price
  • MTRN $120.00
  • NVAX $19.00
  • AVG Volume (30 Days)
  • MTRN 162.8K
  • NVAX 12.9M
  • Earning Date
  • MTRN 08-04-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • MTRN 0.70%
  • NVAX N/A
  • EPS Growth
  • MTRN N/A
  • NVAX N/A
  • EPS
  • MTRN 0.49
  • NVAX 2.97
  • Revenue
  • MTRN $1,719,782,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • MTRN $1.44
  • NVAX $56.85
  • Revenue Next Year
  • MTRN $6.20
  • NVAX N/A
  • P/E Ratio
  • MTRN $163.51
  • NVAX $2.50
  • Revenue Growth
  • MTRN 6.96
  • NVAX 25.92
  • 52 Week Low
  • MTRN $69.10
  • NVAX $5.01
  • 52 Week High
  • MTRN $123.21
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • MTRN 53.03
  • NVAX 56.40
  • Support Level
  • MTRN $73.61
  • NVAX $6.91
  • Resistance Level
  • MTRN $80.10
  • NVAX $7.44
  • Average True Range (ATR)
  • MTRN 2.24
  • NVAX 0.54
  • MACD
  • MTRN 0.35
  • NVAX 0.01
  • Stochastic Oscillator
  • MTRN 80.08
  • NVAX 31.44

About MTRN Materion Corporation

Materion Corp specializes in the development of specialty engineered alloy systems, inorganic chemicals and powders, precious and non-precious metals, beryllium and beryllium composites, and precision filters and optical coatings. The company operates in four reportable segments: Performance Materials, Electronic Materials, Precision Optics, and Others. The majority of revenue is derived from Electronic Materials which produces chemicals, microelectronics packaging, precious metal, non-precious metal, and specialty metal products, including vapor deposition targets, frame lid assemblies, clad and precious metal pre-forms. The Performance Materials segment provides engineered solutions comprised of beryllium and non-beryllium-containing alloy systems and custom-engineered parts.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: